Systemic Therapy for Invasive Bladder Cancer: The Value Proposition

Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy followed by definitive local treatment should be the treatment of choice for otherwise healthy and robust patients with T2b–T4 invasive bladder cancer.

Detalles Bibliográficos
Autor principal: Raghavan, Derek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912376/
https://www.ncbi.nlm.nih.gov/pubmed/27125752
http://dx.doi.org/10.1634/theoncologist.2016-0074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912376/
https://www.ncbi.nlm.nih.gov/pubmed/27125752
http://dx.doi.org/10.1634/theoncologist.2016-0074

Ejemplares similares